Commit Biologics receives Innobooster Grant from Innovation Fund Denmark

February 14 – 2024

Commit Biologics receives Innobooster Grant from Innovation Fund Denmark

Commit Biologics has received an Innobooster Grant of 5M DKK from the Innovation Fund Denmark (IFD) to support further development of the BiCE technology to fight cancer. This is the 2nd Innobooster Grant Commit Biologics receives from the Innovation Fund Denmark.

Read more about Innovation Fund Denmark.

Back to news

More news

See all news

June 10 – 2024

Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics

Events News

Commit Biologics is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases Poster to be presented on Commit’s Bispecific Complement Engaging (BiCE™) platform Aarhus, …

May 9 – 2024

Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease

Funding News

Financing led by Bioqube Ventures and Novo Holdings Commit is pioneering a novel approach to activating the complement component of the immune system to treat cancer and autoimmune diseases Its unique bispecific technology (BiCE™) …

February 14 – 2024